carnitine has been researched along with Atrophy, Muscle in 28 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to elucidate the efficacy of the combination of L-carnitine and exercise, reported to prevent muscle wasting, for muscle complications (function, volume, and cramping) in patients with liver cirrhosis (LC) who received branched-chain amino acid supplementation." | 7.91 | Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation? ( Abe, M; Hiasa, Y; Hiraoka, A; Hirooka, M; Kiguchi, D; Matsuura, B; Michitaka, K; Ninomiya, T, 2019) |
| "Neuromuscular diseases accompanied by muscle atrophy are likely to lead to secondary carnitine deficiency, owing to the reduced amount of total carnitine stored in the body." | 5.91 | A case of Fukuyama-type congenital muscular dystrophy with acute carnitine deficiency triggered by fever, vomiting, and gastrointestinal bleeding. ( Goto, K; Hiramatsu, M; Imai, K; Korematsu, S; Uchiyama, SI; Uemura, A; Wasada, R, 2023) |
| "A 51-year-old man presented with acute respiratory failure and myoglobinuria precipitated by an infection." | 5.26 | Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure. ( Bertorini, T; DiMauro, S; Sabesin, S; Stadlan, E; Trevisan, C; Yeh, YY, 1980) |
| "The aim of this study was to elucidate the efficacy of the combination of L-carnitine and exercise, reported to prevent muscle wasting, for muscle complications (function, volume, and cramping) in patients with liver cirrhosis (LC) who received branched-chain amino acid supplementation." | 3.91 | Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation? ( Abe, M; Hiasa, Y; Hiraoka, A; Hirooka, M; Kiguchi, D; Matsuura, B; Michitaka, K; Ninomiya, T, 2019) |
| "It can be concluded that L-carnitine supplementation may be a good approach for a multi-targeted therapy for the treatment of cancer-related cachexia." | 3.78 | L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer. ( Argilés, JM; Betancourt, A; Busquets, S; Capdevila, E; López-Soriano, FJ; Macciò, A; Madeddu, C; Mantovani, G; Marmonti, E; Orpí, M; Pin, F; Serpe, R; Toledo, M, 2012) |
| "Carnitine level and carnitine palmityl transferase (CPT) activity were investigated in muscles of patients with infantile and juvenile spinal muscular atrophy and polyneuropathies." | 3.67 | Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment. ( Angelini, C; Armani, M; Bet, L; Bresolin, N; Freddo, L; Tegazzin, V, 1984) |
| "Neuromuscular diseases accompanied by muscle atrophy are likely to lead to secondary carnitine deficiency, owing to the reduced amount of total carnitine stored in the body." | 1.91 | A case of Fukuyama-type congenital muscular dystrophy with acute carnitine deficiency triggered by fever, vomiting, and gastrointestinal bleeding. ( Goto, K; Hiramatsu, M; Imai, K; Korematsu, S; Uchiyama, SI; Uemura, A; Wasada, R, 2023) |
| "l-Carnitine was recently found to downregulate the ubiquitin proteasome pathway (UPP) and increase insulin-like growth factor 1 concentrations in animal models." | 1.43 | l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats. ( Chang, H; Jang, J; Lim, K; Park, J, 2016) |
| "L-Carnitine (CARN) is an essential nutrient and plays a key role in mitochondrial β-oxidation and in the ubiquitin-proteasome system regulation." | 1.42 | Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions. ( Benedini, S; Luzi, L; Montesano, A; Senesi, P; Terruzzi, I, 2015) |
| "Carnitine depletion was associated with a 30% decrease soleus muscle weight, whereas contractile function (expressed per gram of muscle), free coenzyme A, and water content remained unaltered from CON." | 1.42 | Contractile function and energy metabolism of skeletal muscle in rats with secondary carnitine deficiency. ( Bonifacio, A; Bouitbir, J; Kaufmann, P; Krähenbühl, S; Roberts, PA; Singh, F; Urwyler, A, 2015) |
| "Carnitine is a key molecule in energy metabolism that helps transport activated fatty acids into the mitochondria." | 1.40 | The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile. ( Akrami, SM; Rashidi-Nezhad, A; Reymond, A; Saebnouri, H; Talebi, S, 2014) |
| "L-carnitine was withheld for 4 months, during which time serum and muscle levels gradually decreased and no changes were observed in muscle fibers." | 1.28 | Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. ( Corsi, M; D'Iddio, S; Giorcelli, G; Mauriello, A; Palmieri, G; Spagnoli, LG; Vacha, GM, 1990) |
| "A 51-year-old man presented with acute respiratory failure and myoglobinuria precipitated by an infection." | 1.26 | Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure. ( Bertorini, T; DiMauro, S; Sabesin, S; Stadlan, E; Trevisan, C; Yeh, YY, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (39.29) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Murata, K | 1 |
| Kaji, K | 1 |
| Nishimura, N | 1 |
| Enomoto, M | 1 |
| Fujimoto, Y | 1 |
| Takeda, S | 1 |
| Tsuji, Y | 1 |
| Fujinaga, Y | 1 |
| Takaya, H | 1 |
| Kawaratani, H | 1 |
| Namisaki, T | 1 |
| Akahane, T | 1 |
| Yoshiji, H | 1 |
| Uchiyama, SI | 1 |
| Korematsu, S | 1 |
| Wasada, R | 1 |
| Imai, K | 1 |
| Uemura, A | 1 |
| Hiramatsu, M | 1 |
| Goto, K | 1 |
| Noormohammadi, Z | 1 |
| Arghavani, H | 1 |
| Javanbakht, M | 1 |
| Daneshpazhooh, M | 1 |
| Jalili, M | 1 |
| Zhang, N | 1 |
| Valentine, JM | 1 |
| Zhou, Y | 1 |
| Li, ME | 1 |
| Zhang, Y | 1 |
| Bhattacharya, A | 1 |
| Walsh, ME | 1 |
| Fischer, KE | 1 |
| Austad, SN | 1 |
| Osmulski, P | 1 |
| Gaczynska, M | 1 |
| Shoelson, SE | 1 |
| Van Remmen, H | 1 |
| Chen, HI | 1 |
| Chen, Y | 1 |
| Liang, H | 1 |
| Musi, N | 1 |
| Endo, S | 1 |
| Takahashi, T | 1 |
| Sato, M | 1 |
| Noya, Y | 1 |
| Obana, M | 1 |
| Hiraoka, A | 1 |
| Kiguchi, D | 1 |
| Ninomiya, T | 1 |
| Hirooka, M | 1 |
| Abe, M | 1 |
| Matsuura, B | 1 |
| Hiasa, Y | 1 |
| Michitaka, K | 1 |
| Busquets, S | 2 |
| Pérez-Peiró, M | 1 |
| Salazar-Degracia, A | 1 |
| Argilés, JM | 2 |
| Serpe, R | 2 |
| Rojano-Toimil, A | 1 |
| López-Soriano, FJ | 2 |
| Barreiro, E | 1 |
| Ringseis, R | 1 |
| Keller, J | 1 |
| Eder, K | 1 |
| Rashidi-Nezhad, A | 1 |
| Talebi, S | 1 |
| Saebnouri, H | 1 |
| Akrami, SM | 1 |
| Reymond, A | 1 |
| Montesano, A | 1 |
| Senesi, P | 1 |
| Luzi, L | 1 |
| Benedini, S | 1 |
| Terruzzi, I | 1 |
| Roberts, PA | 1 |
| Bouitbir, J | 1 |
| Bonifacio, A | 1 |
| Singh, F | 1 |
| Kaufmann, P | 1 |
| Urwyler, A | 1 |
| Krähenbühl, S | 1 |
| Jang, J | 1 |
| Park, J | 1 |
| Chang, H | 1 |
| Lim, K | 1 |
| Toledo, M | 1 |
| Betancourt, A | 1 |
| Marmonti, E | 1 |
| Orpí, M | 1 |
| Pin, F | 1 |
| Capdevila, E | 1 |
| Madeddu, C | 1 |
| Mantovani, G | 1 |
| Macciò, A | 1 |
| Bresolin, N | 1 |
| Freddo, L | 1 |
| Tegazzin, V | 1 |
| Bet, L | 1 |
| Armani, M | 1 |
| Angelini, C | 1 |
| Schmidt, A | 1 |
| Hässler, A | 1 |
| Buxton, PH | 1 |
| Bertorini, T | 1 |
| Yeh, YY | 1 |
| Trevisan, C | 1 |
| Stadlan, E | 1 |
| Sabesin, S | 1 |
| DiMauro, S | 1 |
| Giovenali, P | 1 |
| Fenocchio, D | 1 |
| Montanari, G | 1 |
| Cancellotti, C | 1 |
| D'Iddio, S | 2 |
| Buoncristiani, U | 1 |
| Pelagaggia, M | 1 |
| Ribacchi, R | 1 |
| Köller, H | 1 |
| Stoll, G | 1 |
| Neuen-Jacob, E | 1 |
| Dippenaar, N | 1 |
| Clauss, RP | 1 |
| Feinendegen, LE | 1 |
| Karpati, G | 1 |
| Carpenter, S | 1 |
| Engel, AG | 1 |
| Watters, G | 1 |
| Allen, J | 1 |
| Rothman, S | 1 |
| Klassen, G | 1 |
| Mamer, OA | 1 |
| Claireaux, AE | 1 |
| Lake, BD | 1 |
| Esiri, MM | 1 |
| Bower, BD | 1 |
| Ross, BD | 1 |
| Borum, PR | 1 |
| Broquist, HP | 1 |
| Roelops, RJ | 1 |
| Spagnoli, LG | 1 |
| Palmieri, G | 1 |
| Mauriello, A | 1 |
| Vacha, GM | 1 |
| Giorcelli, G | 1 |
| Corsi, M | 1 |
| Rogerson, ME | 1 |
| Rylance, PB | 1 |
| Wilson, R | 1 |
| De Sousa, C | 1 |
| Lanigan, C | 1 |
| Rose, PE | 1 |
| Howard, J | 1 |
| Parsons, V | 1 |
| Kimura, S | 1 |
| Miyake, S | 1 |
| Martin, JJ | 1 |
| Vercruyssen, A | 1 |
| de Barsy, T | 1 |
| Ceuterick, C | 1 |
2 reviews available for carnitine and Atrophy, Muscle
| Article | Year |
|---|---|
Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.
Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Humans; Muscle, Skeletal; Muscular | 2013 |
Pathology of muscle.
Topics: Adult; Carnitine; Carnitine O-Palmitoyltransferase; Child; Child, Preschool; Denervation; Female; Gl | 1980 |
2 trials available for carnitine and Atrophy, Muscle
| Article | Year |
|---|---|
l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: A randomized double-blind placebo-controlled study.
Topics: Adult; Aged; Carnitine; Dietary Supplements; Double-Blind Method; Glucocorticoids; Humans; Insulin-L | 2023 |
Carnitine and weakness in haemodialysis patients.
Topics: Administration, Oral; Biopsy; Carnitine; Electromyography; Female; Humans; Isometric Contraction; Ki | 1989 |
24 other studies available for carnitine and Atrophy, Muscle
| Article | Year |
|---|---|
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.
Topics: Animals; Carnitine; Lipopolysaccharides; Liver Cirrhosis; Muscle, Skeletal; Muscular Atrophy; Rats; | 2022 |
A case of Fukuyama-type congenital muscular dystrophy with acute carnitine deficiency triggered by fever, vomiting, and gastrointestinal bleeding.
Topics: Amino Acids; Carnitine; Fatty Acids; Gastrointestinal Hemorrhage; Humans; Male; Muscular Atrophy; Mu | 2023 |
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle health.
Topics: Aging; Animals; Blood Glucose; Carnitine; Cell Line; Ceramides; Female; Gene Expression Regulation; | 2017 |
Effects of l-Carnitine Supplementation, Botulinum Neurotoxin Injection, and Rehabilitation for a Chronic Stroke Patient.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins; Carnitine; Combined Modality Therapy; Dietary Su | 2018 |
Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Topics: Aged; Amino Acids, Branched-Chain; Carnitine; Dietary Supplements; Electric Impedance; Exercise Ther | 2019 |
Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
Topics: Animals; Autophagy; Cachexia; Carcinoma, Hepatocellular; Carnitine; Carnitine O-Palmitoyltransferase | 2020 |
The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile.
Topics: Abnormalities, Multiple; Calcinosis; Carnitine; Carrier Proteins; Child, Preschool; Chromosome Delet | 2014 |
Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions.
Topics: Animals; Carnitine; Cell Differentiation; Cell Line; Cell Survival; Mice; Microtubules; Muscle, Skel | 2015 |
Contractile function and energy metabolism of skeletal muscle in rats with secondary carnitine deficiency.
Topics: Animals; Apoptosis; Biomarkers; Carnitine; Deficiency Diseases; Disease Models, Animal; Energy Metab | 2015 |
l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats.
Topics: Animals; Biomarkers; Carnitine; Dietary Supplements; Enzyme Repression; Hindlimb Suspension; Immunoh | 2016 |
L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer.
Topics: Animals; Cachexia; Carcinoma, Hepatocellular; Carnitine; Caspase 3; Dietary Supplements; Liver Neopl | 2012 |
Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment.
Topics: Acyltransferases; Adult; Animals; Carnitine; Denervation; Humans; Infant; Infant, Newborn; Male; Mus | 1984 |
[Lipid storage myopathy--a contribution to the problem of the differential diagnosis of muscle dystrophy (Duchenne)].
Topics: Age Factors; Carnitine; Child; Diagnosis, Differential; Humans; Lipid Metabolism; Male; Muscular Atr | 1983 |
Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure.
Topics: Acyltransferases; Biopsy; Carnitine; Carnitine O-Acetyltransferase; Carnitine O-Palmitoyltransferase | 1980 |
Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers.
Topics: Carnitine; Energy Metabolism; Female; Humans; Hypertrophy; Male; Middle Aged; Muscle Contraction; Mu | 1994 |
Postpartum manifestation of a necrotising lipid storage myopathy associated with muscle carnitine deficiency.
Topics: Adult; Biopsy; Carnitine; Female; Humans; Lipid Metabolism, Inborn Errors; Muscular Atrophy; Necrosi | 1998 |
Effect of carnitine and essential fatty acid supplementation on the uptake of 11C-carnitine in muscle of a myopathic carnitine-deficient patient using positron emission scintigraphy.
Topics: Carbon Radioisotopes; Carnitine; Child; Child, Preschool; Dietary Supplements; Fatty Acids, Essentia | 1998 |
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.
Topics: Adenosine Triphosphatases; Betaine; Carnitine; Child; Endoplasmic Reticulum; Forearm; Glycogen; Hist | 1975 |
Muscle disorders in the floppy child.
Topics: Biopsy; Carnitine; Child; Glycogen Storage Disease; Humans; Infant; Muscles; Muscular Atrophy; Muscu | 1978 |
Fatal lipid storage myopathy in an infant: case report and autopsy findings.
Topics: Biopsy; Carnitine; Humans; Infant; Lipid Metabolism; Lipid Metabolism, Inborn Errors; Male; Muscle H | 1979 |
Muscle carnitine levels in neuromuscular disease.
Topics: Carnitine; Humans; Methods; Muscles; Muscular Atrophy; Muscular Dystrophies; Neuromuscular Diseases | 1977 |
Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle.
Topics: Aged; Carnitine; Female; Humans; Lipid Metabolism; Male; Middle Aged; Muscles; Muscular Atrophy; Ren | 1990 |
Type II fiber myolysis in a patient with hypocarnitinemia.
Topics: Biopsy; Carnitine; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Intellectual Disabili | 1989 |
Muscle carnitine deficiency in old age. Case report and therapeutic results.
Topics: Aged; Biopsy; Carnitine; Electromyography; Humans; Lipid Metabolism; Lipid Metabolism, Inborn Errors | 1985 |